Neoleukin Therapeutics Inc Price Chart
Neoleukin Therapeutics Inc 6AP.BE Financial and Trading Overview
| Neoleukin Therapeutics Inc stock price | 0.65 EUR |
| Previous Close | 0.69 EUR |
| Open | 0.68 EUR |
| Bid | 0.58 EUR x 0 |
| Ask | 0.78 EUR x 0 |
| Day's Range | 0.67 - 0.68 EUR |
| 52 Week Range | 0.37 - 1.31 EUR |
| Volume | 2.5K EUR |
| Avg. Volume | 103 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6AP.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Neoleukin Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 1.31 EUR |
| 52 Week Low | 0.37 EUR |
| 50-Day Moving Average | 0.74 EUR |
| 200-Day Moving Average | 0.63 EUR |
6AP.BE Share Statistics
| Avg. Volume (3 month) | 103 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Neoleukin Therapeutics Inc Stock
What is a current 6AP.BE stock price?
Neoleukin Therapeutics Inc 6AP.BE stock price today per share is 0.65 EUR.
How to purchase Neoleukin Therapeutics Inc stock?
You can buy 6AP.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neoleukin Therapeutics Inc?
The stock symbol or ticker of Neoleukin Therapeutics Inc is 6AP.BE.
How many shares does Neoleukin Therapeutics Inc have in circulation?
The max supply of Neoleukin Therapeutics Inc shares is 0.
What is Neoleukin Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
Neoleukin Therapeutics Inc PE Ratio is 0.00000000 now.
What was Neoleukin Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
Neoleukin Therapeutics Inc EPS is 0 EUR over the trailing 12 months.